Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
464.24
+5.02 (1.09%)
At close: Sep 26, 2025, 4:00 PM EDT
464.44
+0.20 (0.04%)
After-hours: Sep 26, 2025, 7:00 PM EDT
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.86B in the quarter ending June 28, 2025, with 2.98% growth. This brings the company's revenue in the last twelve months to $43.21B, up 2.05% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.21B
Revenue Growth
+2.05%
P/S Ratio
4.08
Revenue / Employee
$345,696
Employees
125,000
Market Cap
175.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
TMO News
- 4 days ago - Dr. Park CDMO Selects Thermo Fisher Scientific to Equip New Viral Vector Manufacturing Facility - Business Wire
- 4 days ago - Thermo Fisher: A Wide-Moat Leader With Multi-Year Growth Ahead - Seeking Alpha
- 6 days ago - Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces - Business Wire
- 11 days ago - Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge - GlobeNewsWire
- 13 days ago - Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel - Business Wire
- 13 days ago - Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance - Business Wire
- 23 days ago - Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript) - Seeking Alpha
- 26 days ago - Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield, New Jersey Site - Business Wire